Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · MEDICINOVA INC (MNOV)

MediciNova ends $30 million Yorkville equity purchase agreement, effective September 8, 2026

Neutral Impact 2 of 5 financing Written later

MediciNova notified Yorkville on August 31, 2026 that it is terminating the Standby Equity Purchase Agreement dated July 30, 2025, with termination effective September 8, 2026. Under the agreement, the company could have sold up to $30.0 million of its common stock, but it sold only 175,000 shares for $0.2 million, and no borrowings or fees are outstanding.

Key points

  • Standby Equity Purchase Agreement with Yorkville dated July 30, 2025; termination notice delivered August 31, 2026, effective September 8, 2026
  • Agreement allowed sales of up to $30.0 million of common stock; company sold 175,000 shares at $1.39 to $1.40 per share for $0.2 million
  • No outstanding borrowings, advance notices or shares to be issued, and no termination fees owed by either party

The filing

CompanyMEDICINOVA INC (MNOV)
Form8-K, current report
Filed with the SECSep 2, 2026, 7:30 AM ET
Accession number0001193125-26-379348

Items reported: 1.02 Termination of Material Agreement

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 02, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.